Trial intelligence / Profile preview

Pioglitazone versus oral contraceptive pill for endometriosis

IRCT201102195867N1Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of pioglitazone and drospirenone + ethinyl estradiol in endometriosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Symptoms of endometriosis and Stage of endometriosis. Started May 2010; status: completed.

02

Drugs

pioglitazonedrospirenone + ethinyl estradiol
03

Conditions

endometriosis

Beyond the preview

Go deeper on IRCT201102195867N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201102195867N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call